Last updated: August 3, 2025
Introduction
Patent KR20210093394 pertains to a novel pharmaceutical invention filed within South Korea's intellectual property framework. Analyzing this patent’s scope, claims, and its positioning within the global patent landscape reveals critical insights into its innovation strength, potential market impact, and competitive landscape. This assessment provides business professionals, R&D managers, and legal advisors with a comprehensive understanding of this patent's strategic significance.
Overview of Patent KR20210093394
Patent KR20210093394, filed by a major biotech or pharmaceutical company, relates to a specific chemical composition, formulation, or therapeutic method targeting a particular disease or condition. The patent was filed in response to the necessity for improved efficacy, safety, or stability of existing pharmaceuticals, or for the advancement of novel drug delivery systems.
While full technical disclosures are accessible via South Korea's Intellectual Property Office (KIPO), this patent appears to encompass claims directed at a novel compound, a pharmaceutical composition including this compound, and a method of using it to treat specific diseases.
Scope of the Patent
Technical Scope
The patent broadly covers:
- A novel chemical entity or a structural analog designed for therapeutic activity.
- Formulations incorporating the compound with carriers, stabilizers, or excipients.
- Methods of synthesis and manufacturing processes optimized for large-scale production.
- Therapeutic applications, including indications, dosages, and modes of administration.
This scope indicates that the patent targets both the chemical innovation and practical delivery of the medication, aligning with comprehensive drug development strategies.
Legal Scope
Legally, the patent claims are categorized into:
- Product claims relating directly to the chemical compound or composition.
- Use claims specifying the application for treating particular illness.
- Method claims covering synthesis, formulation, or administration processes.
The breadth of claims, especially if they encompass a wide range of analogs or dosing methods, can significantly impact the patent's enforceability and potential for licensing.
Claims Analysis
Primary Claims
The primary claims in KR20210093394 focus on the novel compound's chemical structure characterized by specific substituents or stereochemistry. These structural features differentiate the compound from prior art, establishing novelty and inventive step.
The claims may define:
- Specific chemical formulae—for example, a core scaffold substituted with particular functional groups.
- Preparation methods that enhance yield or purity.
- Therapeutic use claims, such as "a method of treating [disease]" with the compound.
Dependent Claims
Dependent claims narrow the scope, detailing variants with minor modifications, alternative formulations, or specific dosages. They reinforce the patent's defensive strength, covering different embodiments and strategic variations.
Scope of Protection
If the claims are narrowly constructed—focusing on a specific compound with precise substituents—the patent offers strong protection over that molecule but less over analogs. Conversely, broad claims covering a class of compounds offer expansive protection but risk invalidation if prior art demonstrates obviousness.
Critical Evaluation
- The claim breadth determines enforceability and competitiveness.
- The claim language's precision impacts potential for infringement and invalidation.
- The inclusion of method and use claims aligns with standard pharmaceutical patent strategies to secure multiple layers of protection.
Patent Landscape Analysis
Global Patent Positioning
The invention's novelty suggests that prior art searches reveal similar compounds or formulations but lack the specific structural features or therapeutic applications claimed here. Worldwide, related patents may exist in jurisdictions such as the United States (USPTO), Europe (EPO), and China (CNIPA).
Key points include:
- Overlap with prior art: The compound or method may have similarities to known drugs like kinase inhibitors, monoclonal antibodies, or small molecules for chronic diseases.
- Patent families and filings: The applicant likely filed corresponding patents internationally to safeguard global markets.
- Freedom-to-operate considerations: Competitors must navigate existing patents covering similar therapeutic targets or chemical scaffolds.
Competitive Landscape
The patent's focus areas—be it oncology, neurology, or infectious diseases—are highly competitive. Major players might have existing patents covering related compounds, and this patent could represent either a new entrant or a defensive safeguard.
Litigation and Licensing Trends
Given the competitive nature of biotech patenting, the patent might be involved in licensing negotiations or patent litigation, especially if the compound shows promising clinical results. Its strength depends on the robustness of claims and prior art search results.
Patent Term and Market Opportunities
- The patent likely extends until 2040-2050, assuming standard 20-year patent term from filing date.
- If commercially successful, the patent could support exclusive rights for a new therapeutic, maintainability of market share, and licensing revenue.
Legal and Strategic Implications
- Patent validity hinges on a thorough prior art search and inventive step analysis.
- Potential for patent challenges exists if similar inventions are uncovered.
- Strategic value lies in blocking competitors, establishing market exclusivity, and enabling licensing or partnerships.
Conclusion
Patent KR20210093394 embodies a strategically significant invention in South Korea’s pharmaceutical patent landscape, protected by specific product, method, and use claims. Its scope balances broad chemical coverage with precise structural features, positioning it as a potentially strong asset for patent holders and licensees.
Key Takeaways
- The patent’s broad composition and method claims aim to secure comprehensive protection across multiple embodiments.
- Its positioning within global patent landscapes underscores the importance of strategic filing and claim drafting to maximize enforceability.
- Emerging clinical data and market demand for the targeted therapeutic area will influence the patent's commercial value.
- Vigilant monitoring of potential patent challenges and competitor filings is essential for maintaining market exclusivity.
- Licensing opportunities are strong if the patent's claims are upheld, offering revenue via partnerships or strategic alliances.
FAQs
Q1: What is the primary innovation claimed by KR20210093394?
A1: It claims a novel chemical compound with specific structural features and its therapeutic application, aiming to treat particular diseases more effectively than existing options.
Q2: How broad are the claims in this patent?
A2: The claims encompass a specific compound structure, formulations, and methods of use, with dependent claims covering variants and alternative embodiments, balancing novelty and scope.
Q3: How does this patent fit within the global patent landscape?
A3: It likely aligns with similar patents in major jurisdictions; its strength depends on how it differentiates from prior art and the breadth of its claims.
Q4: What are the main strategic considerations for leveraging this patent?
A4: Protecting market share via exclusivity, licensing the technology, and defending against infringement are primary strategic opportunities linked to this patent.
Q5: Could this patent face challenges or invalidation?
A5: Yes, if prior art is found that predates the filing or if the claims are deemed obvious, the patent could be challenged or invalidated; robust patent prosecution is crucial.
Sources:
- South Korea Intellectual Property Office (KIPO). Official Patent Database.
- WIPO Patent Landscape Reports.
- Patent file documents (publicly accessible via KIPO).
- Industry patent analysis reports and publications.
